Results 171 to 180 of about 64,777 (328)

Cancer biomarker development from basic science to clinical practice [PDF]

open access: yes, 2018
The amount of published literature on biomarkers has exponentially increased over the last two decades. Cancer biomarkers are molecules that are either part of tumour cells or secreted by tumour cells.
Ali, Asif   +3 more
core  

Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective study

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
The effectiveness of intraperitoneal chemotherapy using paclitaxel (i.p.‐PTX) in pancreatic ductal adenocarcinoma (PDAC) patients with peritoneal dissemination remains elusive. This study indicated that the i.p.‐PTX therapy may improve survival in selected patients with PDAC, in particular those with occult peritoneal dissemination.
Tomohisa Yamamoto   +33 more
wiley   +1 more source

Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma

open access: yesAnnals of Gastroenterological Surgery
Aim Lymph node metastasis is an adverse prognostic factor in pancreatic ductal adenocarcinoma. However, it remains a challenge to predict lymph node metastasis using preoperative imaging alone.
Susumu Daibo   +9 more
doaj   +1 more source

Synchronous Pancreatic Ductal Adenocarcinomas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy

open access: yesGut and Liver, 2015
Cases of pancreatic ductal adenocarcinoma with multiple masses accompanying underlying pancreatic diseases, such as intraductal papillary mucinous neoplasm, have been reported.
doaj   +1 more source

A severity‐based tumor‐superior mesenteric/portal vein interface grading criteria as a predictor of survival outcomes in pancreatic head ductal adenocarcinoma patients undergoing pancreaticoduodenectomy following neoadjuvant chemoradiotherapy

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
PDAC patients with the radiological severe interface (≥25 contact length and ≥210 degrees circumferential tumor‐SMV/PV interface) may help predict poor survival outcomes preoperatively. Abstract Aim To assess the ability of a new severity‐based tumor‐superior mesenteric/portal vein interface criteria to predict survival outcomes in pancreatic ductal ...
Benson Kaluba   +9 more
wiley   +1 more source

Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma [PDF]

open access: bronze, 2003
Salvatore Minniti   +6 more
openalex   +1 more source

Association Between the Degree of Arterial Contact Angle and Survival in Patients With Borderline Resectable Pancreatic Cancer

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This study evaluated the prognostic impact of arterial contact angle in patients with borderline resectable pancreatic cancer undergoing neoadjuvant therapy and surgery. An arterial contact angle of ≥ 90° was associated with higher R1 resection rates and worse survival outcomes.
Katsuhisa Ohgi   +8 more
wiley   +1 more source

In Silico Pharmacokinetic and Molecular Docking Studies of Natural Plants against Essential Protein KRAS for Treatment of Pancreatic Cancer [PDF]

open access: yesarXiv
A kind of pancreatic cancer called Pancreatic Ductal Adenocarcinoma (PDAC) is anticipated to be one of the main causes of mortality during past years. Evidence from several researches supported the concept that the oncogenic KRAS (Ki-ras2 Kirsten rat sarcoma viral oncogene) mutation is the major cause of pancreatic cancer. KRAS acts as an on-off switch
arxiv  

Expression of HIF-1α in A Pancreatic Ductal Adenocarcinoma in A Patient with Newly Diagnosed Type 2 Diabetes

open access: yesAACE Clinical Case Reports, 2018
: Objective: Newly diagnosed type 2 diabetes mellitus (T2DM) increases the risk of pancreatic cancer by an unknown mechanism. We report a patient diagnosed with T2DM
Jessica R. Weaver, PhD   +3 more
doaj  

Home - About - Disclaimer - Privacy